These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7510213)

  • 1. [Effects of GABA and substance P on metabolism of striatal dopamine following experimental cerebral ischemia].
    Li QY
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):677-9, 702. PubMed ID: 7510213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic changes of striatal monoamines with in vivo microdialysis in ischemic rats].
    Wei ZY
    Zhonghua Yi Xue Za Zhi; 1992 Nov; 72(11):661-3, 702. PubMed ID: 1338702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
    Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
    Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-ischemic treadmill training affects glutamate and gamma aminobutyric acid levels in the striatal dialysate of a rat model of cerebral ischemia.
    Jia J; Hu YS; Wu Y; Liu G; Yu HX; Zheng QP; Zhu DN; Xia CM; Cao ZJ
    Life Sci; 2009 Apr; 84(15-16):505-11. PubMed ID: 19302809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
    Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of dl-3-butylphthalide on the striatum extracellular amino acid and dopamine contents in the rat during cerebral ischemia].
    Huang XX; Hu D; Qu ZW; Zhang JT; Feng YP
    Yao Xue Xue Bao; 1996; 31(4):246-9. PubMed ID: 9208646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
    Reid MS; Herrera-Marschitz M; Ungerstedt U
    Neuroscience; 1990; 36(3):659-67. PubMed ID: 1700330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of D2 receptors and dopamine content in striatum before and after electro-acupuncture treatment in rats.
    Lin Y; Lin X
    Chin Med J (Engl); 2000 May; 113(5):408-11. PubMed ID: 11776094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pyrethroids on dopamine and its metabolites in nigrostriatum of male rats].
    Liu GP; Shi N; Liang JH; Chen L
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):368-70. PubMed ID: 15555315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
    Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis.
    Hillered L; Hallström A; Segersvärd S; Persson L; Ungerstedt U
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):607-16. PubMed ID: 2777932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.